Trial for Treatment Refractory Trigeminal Neuralgia
Public ClinicalTrials.gov record NCT03941834. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
BHV3000-202: Phase 2: A Double-Blind, Placebo Controlled, Crossover Trial of BHV-3000 (Rimegepant) for Treatment Refractory Trigeminal Neuralgia
Study identification
- NCT ID
- NCT03941834
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 65 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Rimegepant Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 24, 2019
- Primary completion
- May 10, 2023
- Completion
- May 10, 2023
- Last update posted
- Jun 9, 2024
2019 – 2023
United States locations
- U.S. sites
- 20
- U.S. states
- 8
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Gilbert Neurology Partners, PLLC/CCT Research | Gilbert | Arizona | 85297 | — |
| Center for Neurohealth DBA Kaizen Brain Center | La Jolla | California | 92037 | — |
| Imaging Clinic at Stanford Neuroscience Health Center | Palo Alto | California | 94304 | — |
| Stanford Hoover Pavilion | Palo Alto | California | 94304 | — |
| Stanford Neuroscience Health Center- SNHC Pharmacy | Palo Alto | California | 94304 | — |
| Stanford Neuroscience Health Center | Palo Alto | California | 94304 | — |
| Stanford University- CAM Building | Stanford | California | 94305 | — |
| SouthCoast Research Center | Miami | Florida | 33136 | — |
| Ochsner Baptist Medical Center | New Orleans | Louisiana | 70115 | — |
| Johns Hopkins Clinical Outpatient Center | Baltimore | Maryland | 21287 | — |
| Johns Hopkins ICTR Clinical Research Unit (CRU) | Baltimore | Maryland | 21287 | — |
| Clinical Research Professionals | Chesterfield | Missouri | 63005 | — |
| Dent Neurosciences Research Center | Amherst | New York | 14226 | — |
| Neurological Surgery Practice of Long Island PLCC | Lake Success | New York | 11042 | — |
| Neurological Surgery | Lake Success | New York | 11042 | — |
| Premier Cardiolog Consultants | Lake Success | New York | 11042 | — |
| Premier Cardiolog Consultants | New Hyde Park | New York | 11042 | — |
| Premier Cardiology Consultants | New Hyde Park | New York | 11042 | — |
| North Suffolk Neurology, PC | Port Jefferson Station | New York | 11776 | — |
| Neurology Diagnostics Inc. | Dayton | Ohio | 45459 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03941834, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 9, 2024 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03941834 live on ClinicalTrials.gov.